Considerations and approaches to expansion of solid organ transplant pharmacist services

被引:2
|
作者
Doligalski, Christina Teeter [1 ]
Anger, Lyndsey Bowman [2 ]
Dick, Travis [3 ]
Feist, Ashley [4 ]
Harris, Matt [5 ]
Masters, Brian [6 ]
Pilch, Nicole [7 ]
Quan, David [8 ]
Sparkes, Tracy [6 ]
Suarez, Tricia [9 ]
Yakubu, Idris [10 ]
机构
[1] UNC Hosp, Dept Pharm, 101 Manning Dr, Chapel Hill, NC 27514 USA
[2] Tampa Gen Hosp, Dept Pharm, Tampa, FL 33606 USA
[3] Univ Rochester, Med Ctr, Dept Pharm, Rochester, NY 14642 USA
[4] Univ Calif San Diego, Dept Pharm, San Diego, CA USA
[5] Duke Univ Hosp, Dept Pharm, Durham, NC USA
[6] Univ Maryland, Med Ctr, Dept Pharm, Baltimore, MD 21201 USA
[7] Med Univ South Carolina, Dept Transplant, Charleston, SC 29425 USA
[8] UCSF Hlth, Dept Clin Pharm, San Francisco, CA USA
[9] Univ Iowa Hosp & Clin, Dept Pharm, Iowa City, IA 52242 USA
[10] Virginia Commonwealth Univ Hlth Syst, Dept Pharm, Richmond, VA USA
关键词
benchmarking; compliance; healthcare quality indicators; organ transplantation; pharmacy; INDUCTION THERAPY;
D O I
10.1002/jac5.1514
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Solid organ transplantation is a lifesaving procedure for thousands of people with irreversible end organ diseases. A multidisciplinary approach with inclusion of a pharmacist in the care of transplant recipients is highly desired and may necessitate the addition of transplant pharmacy resources to existing teams to meet these growing needs. By understanding and leveraging the current landscape of leadership priorities, gathering the data to help define the value of pharmacy services, and compiling a formal proposal, one can systematically approach expansion of clinical pharmacy services. This manuscript seeks to provide a framework that can be utilized by pharmacy and transplant administrators, transplant pharmacists, and advocates for transplant pharmacy services for the purpose of evaluating, proposing, and successfully expanding the number of transplant pharmacist resources, including example job descriptions, return on investment examples, and key publications demonstrating the benefit of transplant and pharmacy services.
引用
收藏
页码:1445 / 1456
页数:12
相关论文
共 50 条
  • [21] Important considerations for drugs, nutritional, and herbal supplements in pediatric solid organ transplant recipients
    Pilch, Nicole A.
    Sell, Megan L.
    McGhee, William
    Venkataramanan, Raman
    PEDIATRIC TRANSPLANTATION, 2021, 25 (01)
  • [22] Counselling, Research Gaps, and Ethical Considerations Surrounding Pregnancy in Solid Organ Transplant Recipients
    Deirdre Sawinski
    Steven J. Ralston
    Lisa Coscia
    Christina L. Klein
    Eileen Y. Wang
    Paige Porret
    Kathleen O’Neill
    Ana S. Iltis
    Journal of Bioethical Inquiry, 2023, 20 : 89 - 99
  • [23] Practical considerations when treating chronic hepatitis E in solid organ transplant recipients
    Choi, David K.
    Martin, Michelle T.
    Chacra, Wadih
    Chan, Christine
    Koppe, Sean
    Landers, Lisa
    Naveed, Ammara
    Mikolajczyk, Adam E.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2021, 43 (03) : 753 - 755
  • [24] Practical considerations when treating chronic hepatitis E in solid organ transplant recipients
    David K. Choi
    Michelle T. Martin
    Wadih Chacra
    Christine Chan
    Sean Koppe
    Lisa Landers
    Ammara Naveed
    Adam E. Mikolajczyk
    International Journal of Clinical Pharmacy, 2021, 43 : 753 - 755
  • [25] Antifungal prophylaxis in solid-organ transplant recipients: Considerations for clinical trial design
    Singh, N
    CLINICAL INFECTIOUS DISEASES, 2004, 39 : S200 - S206
  • [26] Mucormycosis in Solid Organ Transplant
    Alejandro Perez Davila
    Cedric Spak
    Edward A. Dominguez
    Current Fungal Infection Reports, 2022, 16 : 70 - 73
  • [27] Mucormycosis in Solid Organ Transplant
    Davila, Alejandro Perez
    Spak, Cedric
    Dominguez, Edward A.
    CURRENT FUNGAL INFECTION REPORTS, 2022, 16 (02) : 70 - 73
  • [28] Solid organ transplant patients
    Aguado, J. M.
    Iversen, M.
    MYCOSES, 2013, 56 : 16 - 17
  • [29] Malignancies in pediatric solid organ transplant recipients: epidemiology, risk factors, and prophylactic approaches
    Paramesh, Anil
    Cannon, Robert
    Buell, Joseph F.
    CURRENT OPINION IN ORGAN TRANSPLANTATION, 2010, 15 (05) : 621 - 627
  • [30] Cell-free DNA as a solid-organ transplant biomarker: technologies and approaches
    Edwards, Rebecca L.
    Menteer, Jondavid
    Lestz, Rachel M.
    Baxter-Lowe, Lee Ann
    BIOMARKERS IN MEDICINE, 2022, 16 (05) : 401 - 415